MP4CO

DRUG2 trials

Sponsors

Sangart

Conditions

Anemia, Sickle CellHemoglobin SC DiseaseSickle Cell AnemiaSickle Cell DiseaseSickle Cell DisordersSickle Cell Hemoglobin C Disease

Phase 1

Safety Study of MP4CO in Adult Sickle Cell Patients

CompletedNCT01356485

SangartAnemia, Sickle Cell, Hemoglobin SC Disease, Sickle Cell Anemia +3

Start: 2012-01-31End: 2012-12-31Updated: 2013-08-19

Phase 2

Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis

WithdrawnNCT01925001

SangartAnemia, Sickle Cell, Hemoglobin SC Disease, Sickle Cell Anemia +3

Start: 2013-10-31End: 2015-10-31Updated: 2013-10-28